Copyright
©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 352-365
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Figure 6 Kaplan-Meier survival curve by surgical status and metastasis status.
Median survival for NM+/no surgery was 9 (95%CI: 4-14) mo, NM+/surgery was 54 (95%CI: 34-85) mo, NM-/no surgery was 11 (95%CI: 6-17) mo, and NM-/surgery was 142 (95%CI: 92-NA) mo (P < 0.001).
- Citation: Sempokuya T, Forlemu A, Azawi M, Silangcruz K, Khoury N, Ma J, Wong LL. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World J Clin Oncol 2022; 13(5): 352-365
- URL: https://www.wjgnet.com/2218-4333/full/v13/i5/352.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i5.352